13,804 Shares of Cardinal Health, Inc. $CAH Bought by TSG Advice Partners LLC

Key Points

• TSG Advice Partners LLC purchased 13,804 Cardinal Health shares worth approximately $3.28 million during the third quarter. Institutional investors and hedge funds collectively own 87.17% of the company.
• Analysts remain generally positive on Cardinal Health, with 16 Buy ratings and three Holds. The stock has a “Moderate Buy” consensus rating and an average price target of $270.69.
• Cardinal Health exceeded quarterly EPS expectations, reporting $2.91 versus the $2.42 consensus estimate, while revenue rose 5.8% year over year. Insiders sold 210,271 shares worth about $49.6 million over the past 90 days, and the company maintains a $0.5158 quarterly dividend.

TSG Advice Partners LLC purchased a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 13,804 shares of the company's stock, valued at approximately $3,279,000.

Other large investors also recently modified their holdings of the company. Downshift Financial LLC grew its stake in shares of Cardinal Health by 3,666.7% in the third quarter. Downshift Financial LLC now owns 113 shares of the company's stock worth $25,000 after acquiring an additional 110 shares during the last quarter. Investors Research Corp acquired a new position in Cardinal Health during the 2nd quarter valued at $29,000. Maryland Capital Advisors Inc. raised its stake in Cardinal Health by 12,600.0% during the 3rd quarter. Maryland Capital Advisors Inc. now owns 127 shares of the company's stock valued at $28,000 after purchasing an additional 126 shares during the last quarter. Allied Private Wealth LLC acquired a new position in Cardinal Health during the 2nd quarter valued at $30,000. Finally, NBH Bank bought a new stake in Cardinal Health in the 2nd quarter valued at $31,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Cardinal Health

In other news, insider Jessica L. Mayer sold 29,436 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the completion of the sale, the insider owned 33,076 shares of the company's stock, valued at approximately $7,812,220.44. This represents a 47.09% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Stephen M. Mason sold 35,000 shares of the firm's stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the completion of the transaction, the chief executive officer directly owned 18,061 shares of the company's stock, valued at $4,269,620.40. This represents a 65.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 210,271 shares of company stock valued at $49,626,657. 0.12% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

CAH has been the topic of several research analyst reports. Weiss Ratings upgraded shares of Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a research report on Thursday, October 8th. Citigroup boosted their price objective on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a "buy" rating in a report on Wednesday, August 12th. Wall Street Zen raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Sunday, October 25th. Barclays increased their target price on shares of Cardinal Health from $258.00 to $275.00 and gave the company an "overweight" rating in a research note on Thursday, August 13th. Finally, Evercore reissued an "outperform" rating and set a $270.00 target price on shares of Cardinal Health in a research report on Wednesday, August 12th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and a consensus target price of $270.69.

Cardinal Health Stock Up 1.7%

Shares of CAH stock opened at $254.69 on Tuesday. The firm has a market cap of $58.98 billion, a price-to-earnings ratio of 35.23, a PEG ratio of 1.47 and a beta of 0.50. Cardinal Health, Inc. has a 12 month low of $180.45 and a 12 month high of $259.84. The stock has a 50-day moving average price of $238.24 and a 200 day moving average price of $222.52.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The company's revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the company posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st were given a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 0.8%. The ex-dividend date was Thursday, October 1st. Cardinal Health's dividend payout ratio (DPR) is currently 28.49%.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.